Abstract
A Molecular-Based Response Prediction Model to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndrome and Severe Thrombocytopenia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have